Additional Covid-19 Research materials
Synthetic intermediates used in COVID-19-related research include steroid-like and silyl-protected building blocks used in synthesizing antiviral and related therapeutic compounds. Reference standards support synthesis quality control, method development for tracking intermediates, and structure confirmation at each stage of a synthetic route. Sourcing from a dedicated supplier means every intermediate, however structurally complex, arrives with verified identity, documented purity, and a certificate of analysis. These materials are especially relevant to labs working with protected alcohols and epoxide intermediates. These materials support labs working on structurally complex, multi-step synthesis routes.
Showing 1–16 of 328 results
-
(-)-1,6-Epoxyisodihydrocarveol
CAS Number: 35692-59-2
Molecular Formula: C10H16O2
Catalogue Number: RCLS2L140800
-
(1-(Cyanomethyl)cyclopropyl)methyl Methanesulfonate
CAS Number: 152922-86-6
Molecular Formula: C7H11NO3S
Catalogue Number: RCLS2L125622
-
(11Alpha,16Alpha)-9,11-Epoxy-17,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
CAS Number: 14622-47-0
Molecular Formula: C22H28O5
Catalogue Number: RCLS2L140792
-
(1Alpha,3Beta,5Z,7E,22E)-24-Cyclopropyl-1,3-dihydroxy-9,10-Secochola-5,7,10(19),22-tetraen-24-one (90%)
CAS Number: 126860-83-1
Molecular Formula: C27H38O3
Catalogue Number: RCLS2L125325
-
(1R,1’S)-Octahydro-1-(2’-iodo-1’-methylethyl)-7a-methyl-inden-4-ol
CAS Number: N/A
Molecular Formula: C13 H23 I O
Catalogue Number: RCLS2L170260
-
(1R,1’S)-Octahydro-1-(2’-iodo-1’-methylethyl)-7a-methyl-inden-4-one
CAS Number: 145372-32-3
Molecular Formula: C13H21IO
Catalogue Number: RCLS2L170261
-
(1R,2S,4R,6R)-2,4-Bis(tert-butyldimethylsilyloxy)-1-methyl-cyclohexane 1,2-Epoxide
CAS Number: 121289-20-1
Molecular Formula: C19H40O3Si2
Catalogue Number: RCLS2L111707
-
(2-Cyclopropyl-2-oxoethyl)triphenyl-phosphonium Bromide
CAS Number: 112849-15-7
Molecular Formula: C23H22BrOP
Catalogue Number: RCLS2L125426
-
(2R,3R)-2,3-Bis(phenylmethoxy)butanedioic Acid
CAS Number: 138794-81-7
Molecular Formula: C18H1
Catalogue Number: RCLS2L112918
-
(3Beta,22E)-Ergosta-5,7,22-triene-3,24,25-triol-d3
CAS Number: 131550-95-3
Molecular Formula: C28H41D3O3
Catalogue Number: RCLS2L140977
-
(3Beta,4Beta)-3,4-Dihydroxy-chol-5,7-diene-24-carboxylic Acid Methyl Ester
CAS Number: N/A
Molecular Formula: C26H40O4
Catalogue Number: RCLS2L134328
-
(3Beta,5Alpha)5,8-[N,N-(4-Phenylurazole)]-cholest-6,22-diene-3,25-diol-d6
CAS Number: N/A
Molecular Formula: C36H43D6N3O4
Catalogue Number: RCLS2L173876
-
(3beta)-7-Dehydro Cholesterol
CAS Number: 434-16-2
Molecular Formula: C27 H44 O
Catalogue Number: RCLS2L127430
-
(3R-trans)-[2-[3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethyl]diphenyl-phosphine Oxide
CAS Number: 139356-39-1
Molecular Formula: C32H51O3PSi2
Catalogue Number: RCLS2L112013
-
(3S,5S)-3,5-Bis(tert-butyldimethylsilyloxy)-2-methyl-1-cyclohexen-1-ol 1-Trifluoromethanesulfonate
CAS Number: 189894-13-1
Molecular Formula: C20H39F3O5SSi2
Catalogue Number: RCLS2L111706
-
(3S,5S)-3,5-Bis(tert-butyldimethylsilyloxy)-2-methylene-cyclohexanone
CAS Number: 190062-19-2
Molecular Formula: C19H38O3Si2
Catalogue Number: RCLS2L111704
Reference Standards for COVID-19 Related Synthesis and Research
Verified intermediates matter throughout a multi-step synthesis, since an error introduced early is often only caught several steps later, at much greater cost in time and material. Certified reference standards at each stage help synthesis teams confirm they’re building on the right foundation.
Clinivex supplies a range of reference materials relevant to COVID-19 research, including structurally complex protected intermediates, each backed by a certificate of analysis. Our technical team can help source related intermediates through our global supplier network when your synthetic route calls for a variant outside our standard catalogue.
As an ISO 9001:2015 and GMP certified supplier working with pharmaceutical and biotech researchers across the USA and Canada, we focus on accurate documentation and dependable delivery at every stage of your project. We understand that multi-step synthesis projects often need several related intermediates over time, so we work to make repeat sourcing from the same trusted batch straightforward wherever possible.
These intermediates connect back to the broader building blocks category, which covers additional starting materials used across multi-step synthesis routes. Antiviral drug development of this kind is a recurring focus within pharmaceutical and biotech research.
Contact our team to request a quote or check availability for a specific COVID-19 research material.
why Choose Clinivex?
At Clinivex, we earn trust by delivering impeccable service, expert guidance, and reliable solutions that drive long-term success. With a skilled team and customer-first approach, we stand as a leading pharmaceutical reference standards supplier in the USA and Canada.
Dedicated Towards Betterment
Driven by innovation, committed to progress.
One-Stop Product Source
All-in-one destination for trusted scientific solutions.
Where Trust Meets Innovation
Blending trust, accuracy, and innovation for groundbreaking results.
Fast and Courteous Customer Service
Merging reliability, accuracy, and innovation to redefine excellence.
Have questions? Get in touch!
Just fill in your details and our representatives will get back to you soon!
Frequently Asked Questions
They are largely synthetic intermediates used in building and verifying multi-step synthesis routes for antiviral and related therapeutic compounds studied during COVID-19 research.
Confirming the identity and purity of each intermediate helps catch errors early, before they carry through several additional synthetic steps and become far more costly to trace and correct.
No. These are synthetic intermediates and building blocks used during the research and development of antiviral compounds, not finished drug or vaccine products themselves.
Join other members of the R&D community getting the latest news, information and guides.
